RESEARCH WORKSPACE

1,018 U.S. candidate accounts. Evidence first.

The universe is built. Reviewed accounts are scored only after checking public regulatory, product, funding, leadership and timing evidence. Database matches remain candidates until that review is complete.

PHASE ONE RESEARCH

Candidate universe + evidence-reviewed cohort.

FDA, company sites, HHS/NIH, MedTech Innovator and reputable funding/news sources drive the review. Apollo is used only for broad candidate discovery.

CANDIDATE UNIVERSE1,018U.S. accounts discovered
EVIDENCE REVIEWED24scored against public evidence
GOLD12highest fit + timing + access
SILVER11strong fit, lower immediate priority
Showing evidence-reviewed accounts
Scroll accounts ↓
Company
HQ
Segment
Stage
Account IQ
Top signal
Top stakeholder
Lead IQ
Next action
Loading research data...
RESEARCH SCHEMA

What each row will contain.

The account score should be inspectable. A high score needs evidence.

FITWho are they?

segment · funding · size · product · geography

CAPABILITYWhat is missing?

regulated software · SQA · V&V · cyber · QMS clues

REGULATORYWhere are they?

RUO · clinical · FDA path · MDR · submission stage

INTENTWhy now?

crisis · funding · hiring · product shift · deadline

PEOPLEWho should we call?

CTO · VP R&D · RA/QA · founder · software owner

SCORING OUTPUT

The table should produce action, not just rankings.

Each researched account ends with a clear selling decision.

1Account IQ

fit + capability + regulatory timing

2Intent

fresh signal and urgency

3Lead IQ

best stakeholder and access

4Tier

Gold · Silver · nurture · disqualify

5Next action

call · email · intro · event · monitor

ABOUT ME

See my broader GTM work.

AI GTM strategy, account intelligence and company-specific sales work samples at CI Flow.

View profile →